Momenta Pharmaceuticals, Inc. (MNTA)

[floblu14]

The only aspect on the webcast I found of consequence was Storer's mentioning the identical 20mg and 40mg syringes....

Agreed. In addition, here are other aspects of Scott's astute presentation:

40MG

A. More & more confident of 40MG approval in the "not too distant future". (He used various similar terminology several times to express high confidence in approval at any time.)
B. MNTA has a joint commercialization group with Sandoz.
C. "FDA aware of the district court's decision on January 30" & other current events. [They are talking.]

M923

A. Received phone calls from "multiple parties" seeking an outright purchase of this asset. (However, MNTA seems to be leaning towards various types of collaborations.)

Here's the clinical trial site -

Estimated Study Completion Date: April 2017

ClinicalTrials.gov processed this record on February 15, 2017

https://clinicaltrials.gov/ct2/show/NCT02581345